(Q24234206)

https://api.crossref.org/works/10.1002%2F14651858.CD005943.PUB4

Effects of vaginal progesterone on pain and uterine contractility in patients with threatened abortion before twelve weeks of pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005943.PUB4

Dydrogesterone in threatened miscarriage: a Malaysian experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005943.PUB4

A randomised trial of progesterone prophylaxis after midtrimester amniocentesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005943.PUB4

Dydrogesterone in the reduction of recurrent spontaneous abortion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005943.PUB4

Efficacy of 17α-Hydroxyprogesterone Caproate in the Prevention of Premature Labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005943.PUB4

Progesterone supplementation during early gestations after IVF or ICSI has no effect on the delivery rates: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005943.PUB4

Dydrogesterone in threatened abortion: pregnancy outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005943.PUB4

The effect of 17 alpha-hydroxyprogesterone caproate/oestradiol valerate on the development and outcome of early pregnancies following in vitro fertilization and embryo transfer: a prospective and randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005943.PUB4

Double-blind study of effect of 17-hydroxyprogesterone caproate on abortion rate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005943.PUB4

Progesterone implantation in habitual abortion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005943.PUB4

Endocrinology of recurrent pregnancy loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005943.PUB4

A prospective longitudinal population-based study of clinical miscarriage in an urban Swedish population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005943.PUB4

Paternal age and maternal age are risk factors for miscarriage; results of a multicentre European study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005943.PUB4

The changing role of progesterone in preterm labour

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005943.PUB4

Progesterone for the prevention of preterm birth: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005943.PUB4

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005943.PUB4

Progestogen for preventing miscarriage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005943.PUB4

A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005943.PUB4

Pregnancy losses in young Australian women: findings from the Australian Longitudinal Study on Women's Health

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005943.PUB4

Termination of second-trimester pregnancy by mifepristone combined with misoprostol versus intra-amniotic injection of ethacridine lactate (Rivanol®): a systematic review of Chinese trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005943.PUB4

The impact of dydrogesterone supplementation on hormonal profile and progesterone-induced blocking factor concentrations in women with threatened abortion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005943.PUB4

Uterine muscle relaxant drugs for threatened miscarriage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005943.PUB4

Fetal loss following ultrasound diagnosis of a live fetus at 6-10 weeks of gestation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005943.PUB4

Does high body mass index increase the risk of miscarriage after spontaneous and assisted conception? A meta-analysis of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005943.PUB4

Role of the infections in recurrent spontaneous abortion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005943.PUB4

In vitro fertilization is associated with an increase in major birth defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005943.PUB4

The diagnostic value of beta-human chorionic gonadotropin, progesterone, CA125 in the prediction of abortions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005943.PUB4

Group B streptococci colonization in pregnant women: risk factors and evaluation of the vaginal flora.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005943.PUB4

Does the presence of a funnel increase the risk of adverse perinatal outcome in a patient with a short cervix?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005943.PUB4

Maternal and perinatal outcome in women with threatened miscarriage in the first trimester: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005943.PUB4

Progestational agents for treating threatened or established preterm labour

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005943.PUB4

Genetic factors as a cause of miscarriage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005943.PUB4

Role of progesterone and progestin therapy in threatened abortion and preterm labour

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005943.PUB4

Progesterone-mediated immunomodulation in pregnancy: its relevance to leukocyte immunotherapy of recurrent miscarriage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005943.PUB4

A prospective, randomized, placebo-controlled trial on the use of mifepristone with sublingual or vaginal misoprostol for medical abortions of less than 9 weeks gestation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005943.PUB4

Evidence for high frequency of chromosomal mosaicism in spontaneous abortions revealed by interphase FISH analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005943.PUB4

International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) revised glossary of ART terminology, 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005943.PUB4